当前位置:首页 - 行情中心 - 京新药业(002020) - 财务分析 - 现金流量表

京新药业

(002020)

  

流通市值:107.00亿  总市值:127.26亿
流通股本:7.24亿   总股本:8.61亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金949,825,279.233,786,397,989.292,846,292,493.751,855,922,463.22
  收到的税费返还11,189,012.8246,620,740.7838,807,179.7226,643,984.94
  收到其他与经营活动有关的现金21,780,413.13113,274,579.7105,589,670.5167,221,938.17
  经营活动现金流入小计982,794,705.183,946,293,309.772,990,689,343.981,949,788,386.33
  购买商品、接受劳务支付的现金319,050,733.691,432,363,922.981,020,986,605.26691,112,290.9
  支付给职工以及为职工支付的现金167,685,869.19628,410,872.32483,059,750.78335,413,164.49
  支付的各项税费148,980,607.24353,287,492.08299,252,402.1220,624,139.61
  支付其他与经营活动有关的现金165,221,029.09750,883,949.55571,906,772.47309,730,367.08
  经营活动现金流出小计800,938,239.213,164,946,236.932,375,205,530.611,556,879,962.08
  经营活动产生的现金流量净额181,856,465.97781,347,072.84615,483,813.37392,908,424.25
二、投资活动产生的现金流量:
  收回投资收到的现金1,634,260,381.922,709,900,1002,013,000,0001,574,000,000
  取得投资收益收到的现金25,639,901.0927,159,592.4525,444,241.9420,377,995.36
  处置固定资产、无形资产和其他长期资产收回的现金净额256,2333,887,457.6396,616.9133,980.6
  投资活动现金流入小计1,660,156,516.012,740,947,150.052,038,840,858.841,594,511,975.96
  购建固定资产、无形资产和其他长期资产支付的现金88,213,905.44202,850,821.93158,475,046.19122,922,973.01
  投资支付的现金1,867,633,569.282,170,990,3521,365,900,000839,000,000
  投资活动现金流出小计1,955,847,474.722,373,841,173.931,524,375,046.19961,922,973.01
  投资活动产生的现金流量净额-295,690,958.71367,105,976.12514,465,812.65632,589,002.95
三、筹资活动产生的现金流量:
  取得借款收到的现金-566,978,516.64372,767,886.11283,131,386.14
  收到其他与筹资活动有关的现金89,042,500368,162.81368,162.81368,162.81
  筹资活动现金流入小计89,042,500567,346,679.45373,136,048.92283,499,548.95
  偿还债务支付的现金70,000,000567,000,000442,000,000282,000,000
  分配股利、利润或偿付利息支付的现金-288,540,870.41288,540,870.41288,540,870.41
  其中:子公司支付给少数股东的股利、利润-3,687,124.663,687,124.663,687,124.66
  支付其他与筹资活动有关的现金16,744,654.88627,554,733.13623,973,550.36621,318,118.66
  筹资活动现金流出小计86,744,654.881,483,095,603.541,354,514,420.771,191,858,989.07
  筹资活动产生的现金流量净额2,297,845.12-915,748,924.09-981,378,371.85-908,359,440.12
四、汇率变动对现金及现金等价物的影响-10,431,386.1-7,217,125.84-2,087,506.29202,617.31
五、现金及现金等价物净增加额-121,968,033.72225,486,999.03146,483,747.88117,340,604.39
  加:期初现金及现金等价物余额512,675,332.7287,144,932.7287,144,932.7287,144,932.7
  期末现金及现金等价物余额390,707,298.98512,631,931.73433,628,680.58404,485,537.09
补充资料:
  净利润-766,667,967.92-392,203,288.29
  资产减值准备-53,295,486.44-6,014,437.25
  固定资产和投资性房地产折旧-252,057,462.72-148,129,426.4
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-252,057,462.72-148,129,426.4
  无形资产摊销-21,257,731.27-9,077,769.18
  长期待摊费用摊销-15,380,447.38-8,031,506.84
  处置固定资产、无形资产和其他长期资产的损失-574,497.63-256,693.52
  固定资产报废损失-50,777.86-39,516.37
  公允价值变动损失--9,470,848.64--67,808.22
  财务费用--33,345,222.17-164,818.72
  投资损失--17,108,923.46--12,490,027.76
  递延所得税-8,951,161.55--7,025,358.05
  其中:递延所得税资产减少-4,326,434.38--10,690,217.42
    递延所得税负债增加-4,624,727.17-3,664,859.37
  存货的减少--5,227,251.15--40,660,090.63
  经营性应收项目的减少--26,571,327.94--11,156,408.46
  经营性应付项目的增加--258,731,692.52--106,638,983.81
  其他--437,868.71--
  现金的期末余额-512,631,931.73-404,485,537.09
  减:现金的期初余额-287,144,932.7-287,144,932.7
  现金及现金等价物的净增加额-225,486,999.03-117,340,604.39
公告日期2026-04-242026-04-242025-10-302025-08-27
审计意见(境内)标准无保留意见
TOP↑